An interventional study of Design Thinking and Focus Groups in Autism Spectrum Disorder and Patient Engagement, sponsored by Thomas Jefferson University. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-05.
Sponsored by Thomas Jefferson University · Not applicable, Interventional, and Other
Rios-Vega L, Rising K, Fields M, Freedman B, Toole N, Ramos J, Schaaf R. Engaging Diverse Stakeholders to Improve Therapy Access for Hispanic and Latino Autist…PubMed 39970258 ↗
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 604 studies in Autistic Disorder with a site in United States — 123 open to participants now, 152 under way, 3 of them phase 3. Autistic Disorder · United States.
Among the 604 studies in Autistic Disorder with a site in United States, this one is the 90th largest by enrollment of the 505 interventional ones that give a count, is one of 31 that started in 2024, is one of 296 with no phase, and was the 488th registered.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
Browse Autistic Disorder studies →123 of the 604 studies in Autistic Disorder with a site in United States are open now. Recruiting first, the newest first:
Children's Mercy Hospital Kansas City · Sites in United States
Ages 8–12
Northeastern University · Sites in United States
Ages 33 mo–71 mo
Vanderbilt University Medical Center · Sites in United States
Ages 36 mo–72 mo
University of Wisconsin, Madison · Sites in United States
Massachusetts General Hospital · Sites in United States
Ages 7–17
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 184 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 144 (78%) stop at 75 or younger; 150 take children under 18; 56 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
604 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 55 · Phase 2 122 · Phase 3 43 · Phase 4 18
First in 1997; this study’s year is marked. 31 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 130 is above the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Median enrollment 44 across the 505 interventional studies, 135 across the 96 observational. Of the 409 that completed or were terminated, 143 (35%) have results posted.
This tab as a report to print or save as PDF → With an account.
73 of 604 have an industry lead sponsor. The 10 most frequent:
Thomas Jefferson University is the lead sponsor of 394 studies on the registry; 69 are open to participants now.
Of its 45 completed or terminated interventional studies of FDA-regulated products, 21 (47%) have results posted.
Thomas Jefferson University has 1 study filed under Autistic Disorder — fewer than ten, so there is no comparison to draw.
34 of the studies in Autistic Disorder with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT02914951Yale UniversityCognitive-Behavioral Therapy for Irritability in Children With Autism Spectrum Disorder and Intellectual Disability | 2026-12 |
| NCT06627205Stanford UniversitySleep Restriction Therapy (SRT) for Sleep Problems in Children With Autism | 2026-12 |
| NCT04805957Rutgers, The State University of New JerseyValidation Digital Bio-markers During Sulforaphane Treatment. | 2026-12-01 |
| NCT07421830Northeastern UniversityAn Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism | 2026-12-31 |
| NCT02000284University of ArkansasMitochondrial Dysfunction in Autism Spectrum Disorder | 2026-12-31 |
Add all 34 to your calendar (.ics) → With an account.
Among the 604 studies in Autistic Disorder with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this study is to compare two methods of engagement in research that include autistic individuals, Hispanic and Latino parents of autistic children, occupational therapy clinicians, teachers, and to use the information collected in the sessions to culturally adapt the occupational therapy Ayres Sensory Integration intervention to improve participation and health outcomes.
The main questions it aims to answer are:
Does the Design Thinking process result in higher stakeholder engagement and satisfaction in the research process in comparison to Focus Groups? Secondary question: Do cultural adaptations using DT data yield higher acceptability and implementation feasibility scores than FG methods?
Participants will:
Racial and ethnic minorities with autistic children experience delays in access to therapy services that can result in poorer outcomes, decreased quality of life, and increased parental and financial stress. Many autism interventions were developed and tested with only White participants, assuming they could be transferable to minority populations. However, research has found that this is not the case and that interventions that are not adapted to an individual's culture and ethnicity do not work as well and are not used as frequently. In this project, we compare two methods of stakeholder engagement, Design Thinking (DT) and Focus Groups (FG), to determine which is better at getting input on the facilitators and barriers to access therapy for autistic children. We focus on Hispanics and Latinos as this is the largest minority group in the US, with one of the fastest-growing groups of autistic children. Our long-term objective is to improve the functional skills and health of Hispanic/Latino autistic children and their families by improving access to an occupational therapy intervention designed to improve daily living skills, socialization, and quality of life. Occupational therapy using Ayres Sensory Integration (OT/ASI) is the only evidence-based intervention that addresses the sensory symptoms in autism. We will use input from these engagement sessions to adapt two versions of the OT/ASI manual: one using DT data and the other using FG data. Outcomes are evaluated following each step. Following the completion of this project, the planned outputs of the study are data on the most effective minority stakeholder engagement method and a culturally adapted OT/ASI manual for Hispanic and Latino autistic children for clinicians and researchers. This information can support future researchers who are engaging Hispanic/Latino individuals or other minority groups in research.
Methods: A randomized mixed methods design is used to evaluate stakeholder engagement methods. Phase one will compare two stakeholder engagement methods (Design Thinking -DT, and Focus Group - FG) and evaluate stakeholder engagement based on the PCORI areas of stakeholder engagement which are operationalized in the Stakeholder-Centric Engagement Evaluation and qualitative data. Phase two utilizes data from phase one to culturally adapt the intervention (two separate intervention protocols will be adapted - one based on FG data and another based on DT data as described below), and obtain stakeholder input on acceptability and feasibility for the Hispanic/Latino autistic population. This provides a second way to measure the effectiveness of each stakeholder engagement method as we will have data to indicate which method (DT or FG) resulted in the highest-rated protocol. The data provided by this study will be used as a basis for a later comparative effectiveness study that will study the culturally adapted protocol's outcomes.
All sessions will be held in Spanish and/or English based on the groups' preferences. Since our intent is to hear the voices of Hispanic/Latino stakeholders, it seems valuable to hold focus groups in Spanish when the participants are Spanish as first language speakers (hereafter referred to as Spanish-first) with audio recordings and later transcription into English for analysis. To accommodate those who prefer English, we will make every effort to group these participants together. When, and if, the Spanish-first groups include participants who prefer English, we will have a Spanish to English translator available. In other words, we will be respectful of each participant's language to optimize their comfort in the engagement sessions.
This project addresses an urgent need to engage stakeholders as part of the research process from conceptualization to dissemination and the need for culturally sensitive evidence-based interventions for Hispanic/Latino autistic children. This project is being developed by a skilled and experienced team of investigators.
1,035 studies on the registry are indexed under Autistic Disorder; 270 are open to participants now.
This study's enrollment of 130 is above the median of 50 across 814 interventional studies indexed under Autistic Disorder.
Browse Autistic Disorder studies →Thomas Jefferson University is the lead sponsor of 394 studies on the registry; 69 are open to participants now.
Of its 45 completed or terminated interventional studies of FDA-regulated products, 21 (47%) have results posted.
Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Autistic person:
Parent/caregiver:
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Design Thinking (DT) process.
Other: Design Thinking
A group of randomized participants (autistic adults, parents/caregivers, OT practitioners, teachers, and cultural experts) will participate in the Focus Group (FG) process.
Other: Focus Groups
Participants attend the DT session through all the stages that include emphasize, define, ideate, prototype and test.
Participants attend the FG that includes the introduction. discussion, and reflection.
Stakeholder-Centric Engagement Evaluation (S-CEE) (Martinez et al., 2021)
The Stakeholder-Centric Engagement Evaluation (S-CEE) is a measure used to assess the frequency and perceived quality of stakeholder engagement across 10 engagement domains, including: collaboration, communication, inclusion, transparency, learning, organizational structure, dissemination, and responsiveness to input. The measure evaluates two dimensions of engagement: frequency ("How Often") and quality ("How Well"). Each item is rated using a 5-point Likert scale. For "How Often," response options range from 1 ("Never") to 5 ("Always"). For "How Well," response options range from 1 ("Poor") to 5 ("Excellent"). Higher scores indicate greater frequency and higher perceived quality of stakeholder engagement. The S-CEE was administered to all participants immediately following the one-time engagement session to capture their perceptions of engagement.
Time frame: Immediately following the one time engagement session
Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM) and the Feasibility of Intervention Measure (FIM) (Weiner et al., 2017)
The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) are validated implementation outcome measures used to assess acceptability, appropriateness, and feasibility of the culturally adapted intervention based on the discussions in the focus groups and design thinking engagement sessions to improve access, use of therapy services, and strategies to adapt an evidence-based therapy intervention. AIM includes 5 items assessing the perceived acceptability of the intervention, IAM includes 4 items assessing the perceived appropriateness or fit of the intervention, and FIM includes 4 items assessing the perceived feasibility of implementing the intervention. Each item is rated using a 5-point Likert scale ranging from 1 ("Completely disagree") to 5 ("Completely agree"). Higher scores indicate greater perceived acceptability, appropriateness, and feasibility of the culturally adapted intervention.
Time frame: Immediately following the cultural adaptation reviews.
Recruitment occurred between February 2024 and September 2025 across Pennsylvania, New Jersey, and Delaware. A community-based, multimodal recruitment strategy was implemented to engage Hispanic/Latino (H/L) autistic adults and parents/caregivers of autistic children, occupational therapists, and teachers, through broad dissemination and relationship-centered outreach. Strategies included distributing bilingual flyers in community settings and outreach to organizations.
| Milestone | Design Thinking | Focus Groups |
|---|---|---|
| Started | 67 | 63 |
| Autistic adults | 3 | 5 |
| Parents/caregivers | 42 | 35 |
| Teachers | 14 | 19 |
| Occupational therapists | 8 | 4 |
| Completed | 67 | 63 |
| Not completed | 0 | 0 |
The Stakeholder-Centric Engagement Evaluation (S-CEE) is a measure used to assess the frequency and perceived quality of stakeholder engagement across 10 engagement domains, including: collaboration, communication, inclusion, transparency, learning, organizational structure, dissemination, and responsiveness to input. The measure evaluates two dimensions of engagement: frequency ("How Often") and quality ("How Well"). Each item is rated using a 5-point Likert scale. For "How Often," response options range from 1 ("Never") to 5 ("Always"). For "How Well," response options range from 1 ("Poor") to 5 ("Excellent"). Higher scores indicate greater frequency and higher perceived quality of stakeholder engagement. The S-CEE was administered to all participants immediately following the one-time engagement session to capture their perceptions of engagement.
| Units on a scale | Design Thinking | Focus Groups |
|---|---|---|
| How Often- Area 1 Issues Important to the Hispanic/Latino population | 4.4 ± 0.6 | 4.3 ± 0.6 |
| How Often-Area 2 Respect and value group member perspectives | 4.8 ± 0.4 | 4.9 ± 0.2 |
| How often- Area 3 Seek group members input | 4.8 ± 0.4 | 4.6 ± 0.6 |
| How often-Area 4 Act on group members input | 4.7 ± 0.5 | 4.4 ± 0.7 |
| How often- Area 5 Mutual learning between group members and research team | 4.8 ± 0.4 | 4.6 ± 0.4 |
| How Often- Area 6 Deal with conflict and disagreements effectively | 4.8 ± 0.4 | 4.8 ± 0.3 |
| How often- Area 7 Communicate with group members using effective methods | 4.7 ± 0.5 | 4.7 ± 0.3 |
| How often- Area 8 Use a clear organizational structure | 4.8 ± 0.4 | 4.8 ± 0.4 |
| How often-Area 9 Be transparent and informative | 4.6 ± 0.6 | 4.6 ± 0.6 |
| How often- Area 10 Involve the group members in dissemination activities | 4.5 ± 0.8 | 4.5 ± 0.9 |
| How well- Area 1 Issues Important to H/L population | 4.2 ± 0.9 | 4.2 ± 0.8 |
| How Well- Area 2 Respect and value group member perspectives | 4.8 ± 0.5 | 4.8 ± 0.3 |
| How well- Area 3 Seek group members input | 4.8 ± 0.5 | 4.7 ± 0.5 |
| How well- Area 4 Act on group members input | 4.7 ± 0.5 | 4.4 ± 0.7 |
| How well-Area 5 Mutual learning between group members and research team | 4.8 ± 0.4 | 4.6 ± 0.5 |
| How well-Area 6 Deal with conflict and disagreements effectively | 4.7 ± 0.4 | 4.7 ± 0.4 |
| How well- Area 7 Communicate with group members using effective methods | 4.7 ± 0.4 | 4.7 ± 0.4 |
| How well-Area 8 Use a clear organizational structure | 4.8 ± 0.5 | 4.8 ± 0.4 |
| How well- Area 9 Be transparent and informative | 4.5 ± 0.7 | 4.7 ± 0.6 |
| How well- Area 10 Involve the group members in dissemination activities | 4.5 ± 0.9 | 4.6 ± 0.8 |
The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM) are validated implementation outcome measures used to assess acceptability, appropriateness, and feasibility of the culturally adapted intervention based on the discussions in the focus groups and design thinking engagement sessions to improve access, use of therapy services, and strategies to adapt an evidence-based therapy intervention. AIM includes 5 items assessing the perceived acceptability of the intervention, IAM includes 4 items assessing the perceived appropriateness or fit of the intervention, and FIM includes 4 items assessing the perceived feasibility of implementing the intervention. Each item is rated using a 5-point Likert scale ranging from 1 ("Completely disagree") to 5 ("Completely agree"). Higher scores indicate greater perceived acceptability, appropriateness, and feasibility of the culturally adapted intervention.
| units on a scale | Design Thinking | Focus Groups |
|---|---|---|
| Acceptability of Intervention Measure (AIM) | 4.45 ± 0.65 | 4.42 ± 0.65 |
| Intervention Appropriateness Measure (IAM) | 4.38 ± 0.66 | 4.35 ± 0.64 |
| Feasibility of Intervention Measure (FIM) | 4.41 ± 0.67 | 4.33 ± 0.65 |
Collected over During the assigned Design Thinking or Focus Group engagement session, a one-time session lasting an average of 3 hours.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Design Thinking | 0/67 (0%) | 0/67 (0%) | 0/67 (0%) |
| Focus Groups | 0/63 (0%) | 0/63 (0%) | 0/63 (0%) |
The number of participants for each arm is correct.
| Age, Continuous(years) | Design Thinking | Focus Groups | Total |
|---|---|---|---|
| Mean | 39.9 ± 11.1 | 40.8 ± 11.2 | 40.3 ± 11.1 |
| Sex: Female, Male(Participants) | Design Thinking | Focus Groups | Total |
|---|---|---|---|
| Female | 55 | 54 | 109 |
| Male | 12 | 9 | 21 |
| Race (NIH/OMB)(Participants) | Design Thinking | Focus Groups | Total |
|---|---|---|---|
| American Indian or Alaska Native | 2 | 3 | 5 |
| Asian | 1 | 0 | 1 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 5 | 1 | 6 |
| White | 19 | 13 | 32 |
| More than one race | 3 | 4 | 7 |
| Unknown or Not Reported | 37 | 42 | 79 |
| Ethnicity (NIH/OMB)(Participants) | Design Thinking | Focus Groups | Total |
|---|---|---|---|
| Hispanic or Latino | 53 | 52 | 105 |
| Not Hispanic or Latino | 14 | 11 | 25 |
| Unknown or Not Reported | 0 | 0 | 0 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Yes — Publications in high-impact autism and occupational therapy journals and presentations at national and international autism research meetings.
Supporting information: Study protocol, Statistical analysis plan
Time frame: Some de-identified data will be available following completion of the study and publication of findings.
Access criteria: Upon written request (reviewed by the principal investigator) information will be shared.
Ran from Feb 2024 to primary completion in Apr 2026, 26 months.
Results were first posted in Nov 2026, 7 months after primary completion.
Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 50. This study's 26 months is close to that.
Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 50.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 5, 2026: primary completion Jul 2026 → Apr 2026 and completion Nov 2026 → Apr 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
Rios-Vega L, Rising K, Fields M, Freedman B, Toole N, Ramos J, Schaaf R. Engaging Diverse Stakeholders to Improve Therapy Access for Hispanic and Latino Autist…PubMed 39970258 ↗
Rios-Vega L, Rising K, Fields M, Freedman B, Toole N, Ramos J, Schaaf R. Engaging Diverse Stakeholders to Improve Therapy Access for Hispanic and Latino Autist…PubMed 39970258 ↗
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.